financetom
Business
financetom
/
Business
/
Longeveron Receives FDA's Fast Track Designation for Lomecel-B as Alzheimer's Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Longeveron Receives FDA's Fast Track Designation for Lomecel-B as Alzheimer's Treatment
Jul 17, 2024 6:31 AM

09:01 AM EDT, 07/17/2024 (MT Newswires) -- Longeveron ( LGVN ) said Wednesday it received fast track designation from the US Food and Drug Administration for its investigational cell therapy Lomecel-B as treatment for mild Alzheimer's. Shares of the company were up 18% in recent Wednesday premarket activity.

The designation is the fifth special regulatory designation given to Lomecel-B, alongside the regenerative medicine advanced therapy designation for the same indication, Longeveron ( LGVN ) said.

Price: 4.1700, Change: +0.65, Percent Change: +18.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK
GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK
Sep 17, 2025
(Reuters) - Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure over five years, after U.S. President Donald Trump arrived in Britain for a second state visit to seal investment deals. The company said its new facilities in the U.S., which made up half its revenue last year, would bridge R&D...
STMicroelectronics to Launch New Microchip Packaging Technology at France Site
STMicroelectronics to Launch New Microchip Packaging Technology at France Site
Sep 17, 2025
04:05 AM EDT, 09/17/2025 (MT Newswires) -- STMicroelectronics ( STM ) said Wednesday that its panel-level packaging technology is expected to begin operations at its site in Tours, France, in Q3 2026. The company said the automated chip-packaging and test process technology increases manufacturing efficiency and reduces costs, as well as enabling the creation of smaller, more powerful, and cost-effective...
Navitas Semiconductor Insider Sold Shares Worth $3,057,450, According to a Recent SEC Filing
Navitas Semiconductor Insider Sold Shares Worth $3,057,450, According to a Recent SEC Filing
Sep 17, 2025
03:45 AM EDT, 09/17/2025 (MT Newswires) -- Brian Long, Director, on September 15, 2025, sold 500,000 shares in Navitas Semiconductor ( NVTS ) for $3,057,450. Following the Form 4 filing with the SEC, Long has control over a total of 1,737,443 Class A common shares of the company, with 22,048 shares held directly and 1,715,395 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1821769/000120101025000025/xslF345X05/wk-form4_1758067892.xml...
Peloton Interactive Insider Sold Shares Worth $1,184,150, According to a Recent SEC Filing
Peloton Interactive Insider Sold Shares Worth $1,184,150, According to a Recent SEC Filing
Sep 17, 2025
03:42 AM EDT, 09/17/2025 (MT Newswires) -- Peter C Stern, Director, President and Chief Executive Officer, on September 15, 2025, sold 152,265 shares in Peloton Interactive ( PTON ) for $1,184,150. Following the Form 4 filing with the SEC, Stern has control over a total of 130,221 Class A common shares of the company, with 130,221 shares held directly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved